6576 POSTER Phase II Safety Study of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as Second-line Therapy in Patients With Hepatocellular Carcinoma
暂无分享,去创建一个
A. Gasbarrini | V. Mazzaferro | J. Bruix | M. Colombo | A. Santoro | L. Bolondi | H. Lim | W. Tak | R. Wiest | M. Reig